251 related articles for article (PubMed ID: 10597293)
21. NEDD8 conjugation in Schistosoma mansoni: genome analysis and expression profiles.
Pereira RV; Gomes Mde S; Olmo RP; Souza DM; Jannotti-Passos LK; Baba EH; Castro-Borges W; Guerra-Sá R
Parasitol Int; 2013 Apr; 62(2):199-207. PubMed ID: 23313772
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.
Amir RE; Haecker H; Karin M; Ciechanover A
Oncogene; 2004 Apr; 23(14):2540-7. PubMed ID: 14676825
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of cul-3b, a novel hominine CUL-3 transcript variant.
Lu L; Zhou ZM; Huang XY; Xu M; Yin LL; Wang H; Xu ZY; Sha JH
Asian J Androl; 2005 Jun; 7(2):205-11. PubMed ID: 15897978
[TBL] [Abstract][Full Text] [Related]
24. Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury.
Zhu Z; Sun L; Hao R; Jiang H; Qian F; Ye RD
Am J Physiol Lung Cell Mol Physiol; 2017 Jul; 313(1):L104-L114. PubMed ID: 28522566
[TBL] [Abstract][Full Text] [Related]
25. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
[TBL] [Abstract][Full Text] [Related]
26. Cloning and expression analysis of a novel salicylate suppressible gene, Hs-CUL-3, a member of cullin/Cdc53 family.
Du M; Sansores-Garcia L; Zu Z; Wu KK
J Biol Chem; 1998 Sep; 273(38):24289-92. PubMed ID: 9733711
[TBL] [Abstract][Full Text] [Related]
27. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins.
Jones J; Wu K; Yang Y; Guerrero C; Nillegoda N; Pan ZQ; Huang L
J Proteome Res; 2008 Mar; 7(3):1274-87. PubMed ID: 18247557
[TBL] [Abstract][Full Text] [Related]
28. ASPP2 inhibits APP-BP1-mediated NEDD8 conjugation to cullin-1 and decreases APP-BP1-induced cell proliferation and neuronal apoptosis.
Chen Y; Liu W; Naumovski L; Neve RL
J Neurochem; 2003 May; 85(3):801-9. PubMed ID: 12694406
[TBL] [Abstract][Full Text] [Related]
29. Neddylation is essential for malaria transmission in
Nayak B; Paul P; Mishra S
mBio; 2024 Apr; 15(4):e0023224. PubMed ID: 38411954
[TBL] [Abstract][Full Text] [Related]
30. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues.
Fay MJ; Longo KA; Karathanasis GA; Shope DM; Mandernach CJ; Leong JR; Hicks A; Pherson K; Husain A
Mol Cancer; 2003 Nov; 2():40. PubMed ID: 14641918
[TBL] [Abstract][Full Text] [Related]
31. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1.
Collier-Hyams LS; Sloane V; Batten BC; Neish AS
J Immunol; 2005 Oct; 175(7):4194-8. PubMed ID: 16177058
[TBL] [Abstract][Full Text] [Related]
32. The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells.
Nag A; Bondar T; Shiv S; Raychaudhuri P
Mol Cell Biol; 2001 Oct; 21(20):6738-47. PubMed ID: 11564859
[TBL] [Abstract][Full Text] [Related]
33. Identification and application of NEDD8 E1 inhibitors.
Bruzzese FJ; Milhollen MA; Gavin JM; Josephine HR; Brownell JE
Methods Mol Biol; 2012; 832():577-88. PubMed ID: 22350913
[TBL] [Abstract][Full Text] [Related]
34. DEN1 deneddylates non-cullin proteins in vivo.
Chan Y; Yoon J; Wu JT; Kim HJ; Pan KT; Yim J; Chien CT
J Cell Sci; 2008 Oct; 121(Pt 19):3218-23. PubMed ID: 18782863
[TBL] [Abstract][Full Text] [Related]
35. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1.
Wu K; Yamoah K; Dolios G; Gan-Erdene T; Tan P; Chen A; Lee CG; Wei N; Wilkinson KD; Wang R; Pan ZQ
J Biol Chem; 2003 Aug; 278(31):28882-91. PubMed ID: 12759363
[TBL] [Abstract][Full Text] [Related]
36. Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway.
Gong L; Yeh ET
J Biol Chem; 1999 Apr; 274(17):12036-42. PubMed ID: 10207026
[TBL] [Abstract][Full Text] [Related]
37. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.
Singer JD; Gurian-West M; Clurman B; Roberts JM
Genes Dev; 1999 Sep; 13(18):2375-87. PubMed ID: 10500095
[TBL] [Abstract][Full Text] [Related]
38. NEDD8 pathways in cancer, Sine Quibus Non.
Watson IR; Irwin MS; Ohh M
Cancer Cell; 2011 Feb; 19(2):168-76. PubMed ID: 21316600
[TBL] [Abstract][Full Text] [Related]
39. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons.
Chen Y; McPhie DL; Hirschberg J; Neve RL
J Biol Chem; 2000 Mar; 275(12):8929-35. PubMed ID: 10722740
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the NEDD8 conjugation pathway by shRNA to UBA3, the subunit of the NEDD8-activating enzyme, suppresses the growth of melanoma cells.
Cheng F; Chen H; Zhang L; Li RH; Liu Y; Sun JF
Asian Pac J Cancer Prev; 2012; 13(1):57-62. PubMed ID: 22502714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
